EMBL
MARTINI

Home

FAQs

Examples

About


Keyword Enhancement Results (AT gene AKS2 NCBI set A vs B)

Significant Terms = 29 , Total Terms = 3048 , Input Data , Raw Output Data
DISEASE     PATHOGEN     RESISTANCE     SYRINGAE     PSEUDOMONAS     AVIRULENT     STRAIN     SUBUNIT     SHOOT     SPONTANEOUS     VEGETATIVE     LOCATED     Hyaloperonospora parasitica     PARASITICS     CDNA     DEFENSE     INFECTION     PROTEIN KINASE     VIRULENCE     LOW LEVEL     RECOMBINANT PROTEIN     INOCULATED     RECOMBINANT     SUSCEPTIBILITIES     RELATIVE     ASSEMBLIES     NUDIX HYDROLASE     RESPONSE     TRANSDUCTION

Term Type Set A
(54 Genes)
Set B
(56 Genes)
Enhancement Factor Adjusted P Value
DISEASE Bioterm 29 (53%) 2 (3%) 15.037 9.546E-08
PATHOGEN Bioterm 30 (55%) 4 (7%) 7.778 1.644E-06
RESISTANCE Bioaction 30 (55%) 4 (7%) 7.778 1.644E-06
SYRINGAE Bioterm 20 (37%) 0 (0%) - 4.965E-06
PSEUDOMONAS Bioterm 20 (37%) 1 (1%) 20.741 7.161E-05
AVIRULENT Bioterm 16 (29%) 0 (0%) - 2.051E-04
STRAIN Bioaction 23 (42%) 3 (5%) 7.951 2.222E-04
SUBUNIT Bioterm 2 (3%) 22 (39%) 10.607 2.895E-04
SHOOT Bioaction 0 (0%) 15 (26%) - 2.796E-03
SPONTANEOUS Bioterm 13 (24%) 0 (0%) - 2.837E-03
VEGETATIVE Bioaction 1 (1%) 16 (28%) 15.429 6.288E-03
LOCATED Bioaction 0 (0%) 14 (25%) - 6.503E-03
HYALOPERONOSPORA PARASITICA Organism 12 (22%) 0 (0%) - 6.620E-03
PARASITICS Bioterm 12 (22%) 0 (0%) - 6.620E-03
CDNA Bioterm 3 (5%) 20 (35%) 6.429 7.286E-03
DEFENSE Bioaction 22 (40%) 5 (8%) 4.563 8.336E-03
INFECTION Bioaction 20 (37%) 4 (7%) 5.185 1.095E-02
PROTEIN KINASE Bioterm 14 (25%) 1 (1%) 14.519 1.193E-02
VIRULENCE Bioterm 16 (29%) 2 (3%) 8.296 1.386E-02
LOW LEVEL Bioterm 0 (0%) 13 (23%) - 1.493E-02
RECOMBINANT PROTEIN Bioterm 11 (20%) 0 (0%) - 1.524E-02
INOCULATED Bioaction 11 (20%) 0 (0%) - 1.524E-02
RECOMBINANT Bioaction 19 (35%) 4 (7%) 4.926 2.299E-02
SUSCEPTIBILITIES Bioterm 15 (27%) 2 (3%) 7.778 2.972E-02
RELATIVE Bioterm 3 (5%) 18 (32%) 5.786 3.210E-02
ASSEMBLIES Bioterm 0 (0%) 12 (21%) - 3.383E-02
NUDIX HYDROLASE Bioterm 10 (18%) 0 (0%) - 3.464E-02
RESPONSE Bioaction 37 (68%) 20 (35%) 1.919 4.448E-02
TRANSDUCTION Bioaction 24 (44%) 8 (14%) 3.111 4.632E-02